COVID-19 Second Wave in India - Wait or Act?
作者信息
Mardikar Harshawardhan, Mardikar Manjusha, Deshpande Niteen, Deshpande Mohan, Admane Parag
机构信息
Spandan Heart Institute & Research Centre, Nagpur, India.
Spandan Heart Institute & Research Centre, Nagpur, India.
出版信息
Am J Med. 2021 Nov;134(11):1309. doi: 10.1016/j.amjmed.2021.06.002. Epub 2021 Jun 25.
Abstract
摘要
相似文献
1
COVID-19 Second Wave in India - Wait or Act?印度的新冠疫情第二波——等待还是行动？
Am J Med. 2021 Nov;134(11):1309. doi: 10.1016/j.amjmed.2021.06.002. Epub 2021 Jun 25.
2
Timing of remdesivir for COVID-19.瑞德西韦用于治疗新冠肺炎的时机。
Med Lett Drugs Ther. 2020 Oct 19;62(1609):161.
3
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).瑞德西韦是否应用于治疗 COVID-19 患者？美国医师学会的快速实践要点（第 1 版）。
Ann Intern Med. 2021 Feb;174(2):229-236. doi: 10.7326/M20-5831. Epub 2020 Oct 5.
4
Update Alert 2: Remdesivir for Adults With COVID-19.最新警报2：用于成人新冠肺炎患者的瑞德西韦。
Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5.
5
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.严重免疫功能低下患者接受多疗程瑞德西韦治疗后，SARS-CoV-2 持续复制。
Int J Infect Dis. 2021 Mar;104:379-381. doi: 10.1016/j.ijid.2020.12.050. Epub 2020 Dec 21.
6
Unmet need for COVID-19 therapies in community settings.社区环境中对新冠病毒治疗的未满足需求。
Lancet Infect Dis. 2021 Nov;21(11):1471. doi: 10.1016/S1473-3099(21)00633-2. Epub 2021 Oct 14.
7
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.替沙格韦单抗/西加韦单抗与瑞德西韦联合治疗对免疫功能低下患者持续性SARS-CoV-2感染的反应欠佳。
J Antimicrob Chemother. 2024 May 2;79(5):1196-1200. doi: 10.1093/jac/dkae082.
8
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing.瑞德西韦治疗新型冠状病毒肺炎：尚无定论，但这可能完全取决于给药时机是否恰当。
Eur J Clin Pharmacol. 2021 Jun;77(6):935-937. doi: 10.1007/s00228-020-03085-7. Epub 2021 Jan 6.
9
Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients.瑞德西韦（Veklury）用于治疗住院的 COVID-19 患者。
Am Fam Physician. 2021 Sep 1;104(3):311-312.
10
Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center.在美国一家学术中心对瑞德西韦同情用药治疗妊娠合并重症2019冠状病毒病的研究。
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100164. doi: 10.1016/j.ajogmf.2020.100164. Epub 2020 Jun 25.
引用本文的文献
1
Remdesivir for Outpatient Management: Time to Wait, Not to Act.用于门诊管理的瑞德西韦：是时候等待，而非行动。
Am J Med. 2022 Mar;135(3):e80. doi: 10.1016/j.amjmed.2021.07.009.
2
The Reply.回复。
Am J Med. 2022 Mar;135(3):e81. doi: 10.1016/j.amjmed.2021.10.034. Epub 2021 Dec 17.
Zotero 插件